“…This has been shown both in fetal and adult wound-healing systems. 10,19,25,26,57,[59][60][61][62] Due to the ability of VEGF to promote inflammatory cell recruitment 63,64 and vascular permeability, 12 it seemed possible that the reduction in scar formation seen after treatment with anti-VEGF antibodies might, therefore, be a result of reduced inflammation. However, we saw no differences in acute inflammation with anti-VEGF antibody treatment, suggesting that the reduction in scarring is not completely a result of reduced inflammation.…”